Newron Pharmaceuticals S.p.A. (LON:0QOI)

Newron Pharmaceuticals Statistics

Total Valuation

LON:0QOI has a market cap or net worth of GBP 372.16 million. The enterprise value is 380.51 million.

Market Cap	372.16M
Enterprise Value	380.51M

Important Dates

The next estimated earnings date is Tuesday, March 24, 2026.

Earnings Date	Mar 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	20.01M
Shares Outstanding	n/a
Shares Change (YoY)	+16.86%
Shares Change (QoQ)	-11.63%
Owned by Insiders (%)	10.54%
Owned by Institutions (%)	14.43%
Float	17.91M

Valuation Ratios

The trailing PE ratio is 17.14.

PE Ratio	17.14
Forward PE	n/a
PS Ratio	7.25
PB Ratio	274.44
P/TBV Ratio	274.61
P/FCF Ratio	17.70
P/OCF Ratio	17.67
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.06, with an EV/FCF ratio of 18.10.

EV / Earnings	17.53
EV / Sales	7.13
EV / EBITDA	12.06
EV / EBIT	12.13
EV / FCF	18.10

Financial Position

The company has a current ratio of 1.51, with a Debt / Equity ratio of 33.23.

Current Ratio	1.51
Quick Ratio	1.40
Debt / Equity	33.23
Debt / EBITDA	1.49
Debt / FCF	2.14
Interest Coverage	8.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	50.97%
Return on Invested Capital (ROIC)	263.58%
Return on Capital Employed (ROCE)	165.16%
Weighted Average Cost of Capital (WACC)	7.98%
Revenue Per Employee	2.33M
Profits Per Employee	986,824
Employee Count	22
Asset Turnover	1.39
Inventory Turnover	n/a

Taxes

In the past 12 months, LON:0QOI has paid 4.76 million in taxes.

Income Tax	4.76M
Effective Tax Rate	17.99%

Stock Price Statistics

The stock price has increased by +105.38% in the last 52 weeks. The beta is 0.70, so LON:0QOI's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+105.38%
50-Day Moving Average	21.84
200-Day Moving Average	12.69
Relative Strength Index (RSI)	42.23
Average Volume (20 Days)	22,270

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0QOI had revenue of GBP 51.33 million and earned 21.71 million in profits. Earnings per share was 1.02.

Revenue	51.33M
Gross Profit	51.33M
Operating Income	30.17M
Pretax Income	26.47M
Net Income	21.71M
EBITDA	30.19M
EBIT	30.17M
Earnings Per Share (EPS)	1.02

Balance Sheet

The company has 37.03 million in cash and 45.06 million in debt, with a net cash position of -8.03 million.

Cash & Cash Equivalents	37.03M
Total Debt	45.06M
Net Cash	-8.03M
Net Cash Per Share	n/a
Equity (Book Value)	1.36M
Book Value Per Share	0.07
Working Capital	17.48M

Cash Flow

In the last 12 months, operating cash flow was 21.06 million and capital expenditures -31,716, giving a free cash flow of 21.03 million.

Operating Cash Flow	21.06M
Capital Expenditures	-31,716
Free Cash Flow	21.03M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 58.78% and 42.30%.

Gross Margin	100.00%
Operating Margin	58.78%
Pretax Margin	51.57%
Profit Margin	42.30%
EBITDA Margin	58.81%
EBIT Margin	58.78%
FCF Margin	40.96%

Dividends & Yields

LON:0QOI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.86%
Shareholder Yield	-16.86%
Earnings Yield	5.83%
FCF Yield	5.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0QOI has an Altman Z-Score of 4.83 and a Piotroski F-Score of 5.

Altman Z-Score	4.83
Piotroski F-Score	5